- Home
- SNDX vs THR Comparison
SNDX vs THR Comparison
Compare SNDX & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- THR
- Stock Information
- Founded
- SNDX 2005
- THR 1954
- Country
- SNDX United States
- THR United States
- Employees
- SNDX N/A
- THR N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- THR Industrial Machinery/Components
- Sector
- SNDX Health Care
- THR Energy
- Exchange
- SNDX Nasdaq
- THR Nasdaq
- Market Cap
- SNDX 1.1B
- THR 906.5M
- IPO Year
- SNDX 2016
- THR 2011
- Fundamental
- Price
- SNDX $16.24
- THR $26.70
- Analyst Decision
- SNDX Strong Buy
- THR
- Analyst Count
- SNDX 10
- THR 0
- Target Price
- SNDX $37.50
- THR N/A
- AVG Volume (30 Days)
- SNDX 2.9M
- THR 202.4K
- Earning Date
- SNDX 08-04-2025
- THR 08-07-2025
- Dividend Yield
- SNDX N/A
- THR N/A
- EPS Growth
- SNDX N/A
- THR 9.96
- EPS
- SNDX N/A
- THR 1.58
- Revenue
- SNDX $77,933,000.00
- THR $491,979,000.00
- Revenue This Year
- SNDX $434.67
- THR $5.01
- Revenue Next Year
- SNDX $108.62
- THR $6.50
- P/E Ratio
- SNDX N/A
- THR $15.86
- Revenue Growth
- SNDX 2126.66
- THR N/A
- 52 Week Low
- SNDX $8.58
- THR $23.05
- 52 Week High
- SNDX $22.50
- THR $33.25
- Technical
- Relative Strength Index (RSI)
- SNDX 79.83
- THR 51.51
- Support Level
- SNDX $15.36
- THR $24.72
- Resistance Level
- SNDX $16.33
- THR $26.06
- Average True Range (ATR)
- SNDX 0.78
- THR 0.91
- MACD
- SNDX 0.31
- THR 0.02
- Stochastic Oscillator
- SNDX 96.87
- THR 61.87
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.